Key statistics
On Wednesday, ALK-Abello A/S (4AJ0:FRA) closed at 28.72, -9.11% below its 52-week high of 31.60, set on Dec 01, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 28.90 |
|---|---|
| High | 28.90 |
| Low | 28.72 |
| Bid | 28.48 |
| Offer | 28.80 |
| Previous close | 28.88 |
| Average volume | 16.90 |
|---|---|
| Shares outstanding | 202.57m |
| Free float | 112.81m |
| P/E (TTM) | 43.81 |
| Market cap | 44.16bn DKK |
| EPS (TTM) | 4.98 DKK |
Data delayed at least 15 minutes, as of Feb 11 2026 11:06 GMT.
More ▼
- ALK receives positive recommendation for EURneffy® 1 mg: A needle-free anaphylaxis treatment for children
- ALK modtager anbefaling om godkendelse af EURneffy® 1 mg: En nålefri anafylaksibehandling til børn
- ALK to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco
- ALK – Financial calendar for the 2026 financial year
- ALK – Finanskalender for regnskabsåret 2026
- Major shareholder announcement
- Storaktionærmeddelelse
- ALK udnævner Edward Jordan til ny direktør for de kommercielle aktiviteter i Nordamerika
- ALK appoints Edward Jordan as new EVP and head of Commercial Operations North America
- Nine-month interim report (Q3) 2025 (unaudited)
More ▼
